Combining biomarkers and TIMI score for prediction of left ventricular systolic dysfunction among patients with STEMI

Biological Markers and Guided Therapy ◽

10.12988/bmgt.2021.91024 ◽

2021 ◽

Vol 8 (1) ◽

pp. 19-25

Author(s):

E.V. Sid'

Keyword(s):

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Download Full-text

349 Improving the utility and cost-effectiveness of NT-proBNP for the screening of patients considered at high risk of left ventricular systolic dysfunction in primary care

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(06)80211-0 ◽

2006 ◽

Vol 5 (1) ◽

pp. 74-74

Author(s):

K GOODE ◽

A CLARK ◽

J BRISTOW ◽

K SYKES ◽

J CLELAND

Keyword(s):

Primary Care ◽

Cost Effectiveness ◽

High Risk ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction

Download Full-text

522 Screening for left ventricular systolic dysfunction in older people in the community

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(04)90387-6 ◽

2004 ◽

Vol 3 (1) ◽

pp. 135

Author(s):

M OMAHONY

Keyword(s):

Older People ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction

Download Full-text

Pentraxin 3: A new biomarker for the diagnosis of both symptomatic and asymptomatic left ventricular systolic dysfunction in the elderly?

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(08)60345-8 ◽

2008 ◽

Vol 7 ◽

pp. 124-124

Author(s):

S ABOURAYA ◽

A ABOURAYA ◽

M HELMII

Keyword(s):

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

The Elderly ◽

Left Ventricular ◽

Pentraxin 3 ◽

Ventricular Systolic Dysfunction

Download Full-text

446 Survival in patients with prevalent all-cause heart failure and borderline left ventricular systolic dysfunction

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(07)60260-4 ◽

2007 ◽

Vol 6 (1) ◽

pp. 93-94

Author(s):

F HOBBS ◽

A ROALFE ◽

R DAVIS ◽

M DAVIES ◽

R HARE

Keyword(s):

Heart Failure ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction

Download Full-text

1327 Patient characteristics, treatment, prognosis and adherence to guidelines in patients with left-ventricular systolic dysfunction as compared to preserved left-ventricular function: a report from the EuroHeart Failure Survey

European Heart Journal ◽

10.1016/s0195-668x(03)94581-7 ◽

2003 ◽

Vol 24 (5) ◽

pp. 252

Author(s):

M LENZEN

Keyword(s):

Left Ventricular Function ◽

Ventricular Function ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Patient Characteristics ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Adherence To Guidelines ◽

Treatment Prognosis

Download Full-text

P2178 Echocardiographic predictors of outcome in patients with mild left-ventricular systolic dysfunction

European Heart Journal ◽

10.1016/s0195-668x(03)95172-4 ◽

2003 ◽

Vol 24 (5) ◽

pp. 411

Author(s):

A ROSSI

Keyword(s):

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Predictors Of Outcome

Download Full-text

1338 What proportion of patients with heart failure and preserved left-ventricular systolic dysfunction has an elevated brain natriuretic peptide?

European Heart Journal ◽

10.1016/s0195-668x(03)94592-1 ◽

2003 ◽

Vol 24 (5) ◽

pp. 255

Author(s):

K HOGG

Keyword(s):

Heart Failure ◽

Brain Natriuretic Peptide ◽

Natriuretic Peptide ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Patients With Heart Failure

Download Full-text

Blockade of the Renin-Angiotensin System: Effect on Mortality in Patients with Left Ventricular Systolic Dysfunction

Cardiology Clinics ◽

10.1016/s0733-8651(18)30129-2 ◽

1994 ◽

Vol 12 (1) ◽

pp. 101-114 ◽

Author(s):

Pitt Bertram

Keyword(s):

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Renin Angiotensin System ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

System Effect ◽

Angiotensin System ◽

Renin Angiotensin

Download Full-text

Faculty Opinions recommendation of Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120774.597955 ◽

2009 ◽

Author(s):

Brian Olshansky

Keyword(s):

Coronary Artery Disease ◽

Risk Factor ◽

Left Ventricular Systolic Dysfunction ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Artery Disease ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1122755.579832 ◽

2008 ◽

Author(s):

Wolfgang Schoels

Keyword(s):

Coronary Artery Disease ◽

Left Ventricular Systolic Dysfunction ◽

Controlled Trial ◽

Stable Coronary Artery Disease ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text